We have located links that may give you full text access.
Late-course accelerated hyperfractionated intensity-modulated radiotherapy for nasopharyngeal adenoid cystic carcinoma: A case report.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists 2019 June 16
Nasopharyngeal adenoid cystic carcinoma is a rare neoplasm characterized by strong local invasiveness and a higher tendency to relapse. Because of the rare cases, there is a little consensus on treatment. We report a case of T3N0 NACC with a positive resection margin treated with postoperative adjuvant radiotherapy. MRI reexamination indicated suspected tumor progression during the course of radiotherapy. In order to improve local control, late-course accelerated hyperfractionated intensity-modulated radiotherapy (LCAF-IMRT) was performed to escalate total dose, which achieved good local control with no significant late toxicity.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app